An industry leading services provider in viral challenge studies and laboratory services supporting product development for customers in infectious and respiratory therapeutics.
Industry leading provider of infectious and respiratory challenge studies
A source for the latest press releases, scientific publications and other media as well as details of investor and scientific events that we attend and host across the world.
First volunteers inoculated with Malaria human challenge agent
A highly specialised virology and immunology laboratory offering a suite of services to support pre-clinical and clinical respiratory drug and vaccine discovery and development.
Volunteers are vital to the work we do. Thousands of people have already taken part in our ethically and regulatory approved clinical studies. Find out how you could join them.
Unparalleled experience in the design, conduct and analysis of human models of disease.
hVIVO can offer a suite of challenge models that can expedite and inform clinical development –
Highly specialised virology and immunology laboratory offering a suite of services to support pre-clinical and clinical respiratory drug and vaccines discovery and development.
Open Orphan plc (ticker: ORPH) is a is a growing niche CRO pharmaceutical services company. hVIVO – part of Open Orphan plc.
Characterisation Study results in Nature Medicine
£5m RSV human challenge study contract win
Trading Update and screening facilities expansion
World Vaccine Congress Washington
Industry leading provider of viral challenge studies
See our latest media coverage
If you are interested in volunteering for one of our trials, please visit: https://flucamp.com/ and complete a registration form – only available for UK residents.